TY - JOUR
T1 - A case of intravascular large B-cell lymphoma associated with transverse myelopathy
AU - Seki, Masanori
AU - Sugawara, Tomohiro
AU - Yamamoto, Katsutoshi
AU - Takahashi, Taro
AU - Harigae, Hideo
PY - 2011/11
Y1 - 2011/11
N2 - We present a 68-year-old man suffering from transverse myelopathy since May 2010. The spinal cord MRI showed a T2-hyperintense lesion invading the Th5 level spinal cord. Although the patient transiently responded to steroid-pulse therapy, his neurological symptoms degenerated three months after wards. On admission, he had an apparent hepatosplenomegaly, but no lymphadenopathy. A laboratory examination revealed bicytopenia and increased levels of LDH and soluble IL-2 receptors. Histological analysis of a skin biopsy specimen demonstrated proliferation of large atypical lymphoid cells positive for CD20 and CD79a in the small capillaries, leading to our diagnosis of intravascular large B-cell lymphoma (IVLBCL). Thus, the patient's progressive myelopathy was probably caused by IVLBCL invasion. The patient responded well to Rituximab-combined CHOP therapy (R-CHOP), and his neurological symptoms improved immediately. A spinal cord MRI showed the disappearance of the abnormal signal after two courses of R-CHOP. IVLBCL often presents with neurological manifestations, including transverse myelopathy.
AB - We present a 68-year-old man suffering from transverse myelopathy since May 2010. The spinal cord MRI showed a T2-hyperintense lesion invading the Th5 level spinal cord. Although the patient transiently responded to steroid-pulse therapy, his neurological symptoms degenerated three months after wards. On admission, he had an apparent hepatosplenomegaly, but no lymphadenopathy. A laboratory examination revealed bicytopenia and increased levels of LDH and soluble IL-2 receptors. Histological analysis of a skin biopsy specimen demonstrated proliferation of large atypical lymphoid cells positive for CD20 and CD79a in the small capillaries, leading to our diagnosis of intravascular large B-cell lymphoma (IVLBCL). Thus, the patient's progressive myelopathy was probably caused by IVLBCL invasion. The patient responded well to Rituximab-combined CHOP therapy (R-CHOP), and his neurological symptoms improved immediately. A spinal cord MRI showed the disappearance of the abnormal signal after two courses of R-CHOP. IVLBCL often presents with neurological manifestations, including transverse myelopathy.
KW - Intravascular large B-cell lymphoma
KW - Rituximab
KW - Transverse myelopathy
UR - http://www.scopus.com/inward/record.url?scp=84862937501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862937501&partnerID=8YFLogxK
M3 - Article
C2 - 22083204
AN - SCOPUS:84862937501
SN - 0385-0684
VL - 38
SP - 1885
EP - 1888
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 11
ER -